Up-regulation of microRNA-16 in glioblastoma inhibits the function of endothelial cells and tumor angiogenesis by targeting Bmi-1

Anti-Cancer Agents in Medicinal Chemistry

Volumn 16, Issue 5, 2016, Pages 609-620

  Chen, Fanfan ^a,b   Chen, Lei ^a,c   He, Hua ^d   Huang, Weiyi ^a   Zhang, Run ^a   Li, Peng ^a,b   Meng, Yicheng ^d   Jiang, Xiaodan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Bmi 1; Endothelial cells; Glioblastoma (GBM); microRNA 16 (miR 16)

Indexed keywords

BMI1 PROTEIN; CD34 ANTIGEN; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA 16; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; BMI1 PROTEIN, HUMAN; MICRORNA; MIRN16 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MOLECULAR THERAPY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL CULTURE; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; VASCULARIZATION;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; GLIOBLASTOMA; HUMANS; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; POLYCOMB REPRESSIVE COMPLEX 1; UP-REGULATION;

EID: 84964059110     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520615666150916092251     Document Type: Article

References (45)

1. Van Meir, E.G.; Hadjipanayis, C.G.; Norden, A.D.; Shu, H.K.; Wen, P.Y.; Olson, J.J. Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin., 2010, 60(3), 166-193.
2. Tao, B.B.; He, H.; Shi, X.H.; Wang, C.L.; Li, W.Q.; Li, B.; Dong, Y.; Hu, G.H.; Hou, L.J.; Luo, C.; Chen, J.X.; Chen, H.R.; Yu, Y.H.; Sun, Q.F.; Lu, Y.C. Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade. J Clin. Neurosci., 2013, 20(5), 717-720.
3. Zhao, Z.; He, H.; Wang, C.; Tao, B.; Zhou, H.; Dong, Y.; Xiang, J.; Wang, L.; Luo, C.; Lu, Y.; Yu, X. Downregulation of Id2 increases chemosensitivity of glioma. Tumour Biol., 2015, 36(6), 4189-4196.
4. Linkous, A.G.; Yazlovitskaya, E.M. Angiogenesis in glioblastoma multiforme: Navigating the maze. Anticancer Agents Med. Chem., 2011, 11(8), 712-718.
5. Zhao, J.; He, H.; Zhou, K.; Ren, Y.; Shi, Z.; Wu, Z.; Wang, Y.; Lu, Y.; Jiao, J. Neuronal transcription 2 factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis. PLoS One, 2012, 7(7), e41506.
6. Park, M.C.; Kang, T.; Jin, D.; Han, J.M.; Kim, S.B.; Park, Y.J.; Cho, K.; Park, Y.W.; Guo, M.; He, W.; Yang, X.L.; Schimmel, P.; Kim, S. Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. Proc. Natl. Acad. Sci. USA, 2012, 109(11), e640-e647.
7. Abba, M.; Mudduluru, G.; Allgayer, H. MicroRNAs in cancer: Small molecules, big chances. Anticancer Agents Med. Chem., 2012, 12(7), 733-743.
8. Papagiannakopoulos, T.; Shapiro, A.; Kosik, K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res., 2008, 68(19), 8164-8172.
9. Lee, S.T.; Chu, K.; Oh, H.J.; Im, W.S.; Lim, J.Y.; Kim, S.K.; Park, C.K.; Jung, K.H.; Lee, S.K.; Kim, M.; Roh, J.K. Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J. Neurooncol., 2011, 102(1), 19-24.
10. Silber, J.; Lim, D.A.; Petritsch, C.; Persson, A.I.; Maunakea, A.K.; Yu, M.; Vandenberg, S.R.; Ginzinger, D.G.; James, C.D.; Costello, J.F.; Bergers, G.; Weiss, W.A.; Alvarez-Buylla, A.; Hodgson, J.G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med, 2008, 6, 14.
11. Chen, L.; Chen, X.R.; Zhang, R.; Li, P.; Liu, Y.; Yan, K.; Jiang, X.D. MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression. J. Neurooncol., 2013, 112(1), 59-66.
12. Chen, Q.; Lu, G.; Cai, Y.; Li, Y.; Xu, R.; Ke, Y.; Zhang, S. MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1. Neuro. Oncol., 2014, 16(5), 637-651.
13. Santoro, M.M.; Nicoli, S. miRNAs in endothelial cell signaling: The endomiRNAs. Exp. Cell Res., 2013, 319(9), 1324-1330.
14. Bhattacharya, R.; Nicoloso, M.; Arvizo, R.; Wang, E.; Cortez, A.; Rossi, S.; Calin, G.A.; Mukherjee, P. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res., 2009, 69(23), 9090-9095.
15. Young, L.E.; Moore, A.E.; Sokol, L.; Meisner-Kober, N.; Dixon, D.A. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Mol. Cancer Res., 2012, 10(1), 167-180.
16. Tung, Y.T.; Huang, P.W.; Chou, Y.C.; Lai, C.W.; Wang, H.P.; Ho, H.C.; Yen, C.C.; Tu, C.Y.; Tsai, T.C.; Yeh, D.C.; Wang, J.L.; Chong, K.Y.; Chen, C.M. Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16. Oncotarget, 2015.
17. Bonci, D.; Coppola, V.; Musumeci, M.; Addario, A.; Giuffrida, R.; Memeo, L.; D’Urso, L.; Pagliuca, A.; Biffoni, M.; Labbaye, C.; Bartucci, M.; Muto, G.; Peschle, C.; De Maria R. The miR-15amiR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med., 2008, 14(11), 1271-1277.
18. Yang, T.Q.; Lu, X.J.; Wu, T.F.; Ding, D.D.; Zhao, Z.H.; Chen, G.L.; Xie, X.S.; Li, B.; Wei, Y.X.; Guo, L.C.; Zhang, Y.; Huang, Y.L.; Zhou, Y.X.; Du, Z.W. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-kappaB1/MMP9 signaling pathway. Cancer Sci., 2014, 105(3), 265-271.
19. Sun, C.Y.; She, X.M.; Qin, Y.; Chu, Z.B.; Chen, L.; Ai, L.S.; Zhang, L.; Hu, Y. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF. Carcinogenesis, 2013, 34(2), 426-435.
20. Caporali, A.; Emanueli, C. MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc Med., 2011, 21(6), 162-166.
21. Chen, L.; Chen, X.R.; Chen, F.F.; Liu, Y.; Li, P.; Zhang, R.; Yan, K.; Yi, Y.J.; Xu, Z.M.; Jiang, X.D. MicroRNA-107 inhibits U87 glioma stem cells growth and invasion. Cell Mol. Neurobiol., 2013, 33(5), 651-657.
22. Weidner, N.; Carroll, P.R.; Flax, J.; Blumenfeld, W.; Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 1993, 143(2), 401-409.
23. Weidner, N. Chapter 14. Measuring intratumoral microvessel density. Methods Enzymol, 2008, 444, 305-323.
24. Wang, H.; Xu, T.; Jiang, Y.; Xu, H.; Yan, Y.; Fu, D.; Chen, J. The challenges and the promise of molecular targeted therapy in malignant gliomas. Neoplasia, 2015, 17(3), 239-255.
25. Reymond, N.; Im, J.H.; Garg, R.; Cox, S.; Soyer, M.; Riou, P.; Colomba, A.; Muschel, R.J.; Ridley, A.J. RhoC and ROCKs regulate cancer cell interactions with endothelial cells. LID - S1574-7891(15)00019-8 [pii]LID - 10.1016/j.molonc.2015.01.004 [doi]. Mol. Oncol., 2015.
26. Bergers, G.; Benjamin, L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer, 2003, 3(6), 401- 410.
27. Liu, Z.; Fan, F.; Wang, A.; Zheng, S.; Lu, Y. Dll4-Notch signaling in regulation of tumor angiogenesis. J. Cancer Res. Clin. Oncol., 2014, 140(4), 525-536.
28. Gilbertson, R.J.; Rich, J.N. Making a tumour’s bed: Glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer, 2007, 7(10), 733-736.
29. Baguley, B.C. Antivascular therapy of cancer: DMXAA. Lancet Oncol., 2003, 4(3), 141-148.
30. Ferrara, N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer, 2002, 2(10), 795-803.
31. Smits, M.; Nilsson, J.; Mir, S.E.; Van der Stoop, P.M.; Hulleman, E.; Niers, J.M.; De Witt Hamer, P.C; Marquez, V.E.; Cloos, J.; Krichevsky, A.M.; Noske, D.P.; Tannous, B.A.; Wurdinger, T. miR-101 is down- regulated in glioblastoma resulting in EZH2- induced proliferation, migration, and angiogenesis. Oncotarget, 2010, 1(8), 710-720.
32. Mlcochova, J.; Faltejskova, P.; Nemecek, R.; Svoboda, M.; Slaby, O. MicroRNAs targeting EGFR signalling pathway in colorectal cancer. J. Cancer Res. Clin. Oncol., 2013, 139(10), 1615-1624.
33. Wurdinger, T.; Tannous, B.A.; Saydam, O.; Skog, J.; Grau, S.; Soutschek, J.; Weissleder, R.; Breakefield, 26 X.O.; Krichevsky, A.M. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell, 2008, 14(5), 382-393.
34. Vandertop, W.P.; De Vries, H.E; Reijerkerk, A. Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J., 2012, 26(6), 2639-2647.
35. Bottoni, A.; Piccin, D.; Tagliati, F.; Luchin, A.; Zatelli, M.C.; degli, U.E.C. miR-15a and miR-16-1 down- regulation in pituitary adenomas. J. Cell Physiol., 2005, 204(1), 280-285.
36. Shi, X.; Tao, B.; He, H.; Sun, Q.; Fan, C.; Bian, L.; Zhao, W.; Lu, Y.C. MicroRNAs-based network: a novel therapeutic agent in pituitary adenoma. Med. Hypotheses., 2012, 78(3), 380-384.
37. Cui, X.; Witalison, E.E.; Chumanevich, A.P.; Chumanevich, A.A.; Poudyal, D.; Subramanian, V.; Schetter, A.J.; Harris, C.C.; Thompson, P.R.; Hofseth, L.J. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest. PLoS One, 2013, 8(1), e53791.
38. Cimmino, A.; Calin, G.A.; Fabbri, M.; Iorio, M.V.; Ferracin, M.; Shimizu, M.; Wojcik, S.E.; Aqeilan, R.I.; Zupo, S.; Dono, M.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C.G.; Kipps, T.J.; Negrini, M.; Croce, C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA, 2005, 102(39), 13944-13949.
39. Ohgaki, H.; Kleihues, P. Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol., 44 2007, 170(5), 1445-1453.
40. Jenny, B.; Harrison, J.A.; Baetens, D.; Tille, J.C.; Burkhardt, K.; Mottaz, H.; Kiss, J.Z.; Dietrich, P.Y.; De Tribolet N; Pizzolato, G.P.; Pepper, M.S. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. J. Pathol., 2006, 209(1), 34-43.
41. Vlachostergios, P.J.; Papandreou, C.N. The Bmi-1/NF-kappaB/ VEGF story: Another hint for proteasome involvement in glioma angiogenesis. J. Cell Commun. Signal., 2013, 7(4), 235-237.
42. Kim, J.H.; Yoon, S.Y.; Jeong, S.H.; Kim, S.Y.; Moon, S.K.; Joo, J.H.; Lee, Y.; Choe, I.S.; Kim, J.W. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast, 2004, 13(5), 383-388.
43. Yin, T.; Wei, H.; Leng, Z.; Yang, Z.; Gou, S.; Wu, H.; Zhao, G.; Hu, X.; Wang, C. Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells. Chemotherapy, 2011, 57(6), 488- 496.
44. Godlewski, J.; Nowicki, M.O.; Bronisz, A.; Williams, S.; Otsuki, A.; Nuovo, G.; Raychaudhury, A.; Newton, H.B.; Chiocca, E.A.; Lawler, S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and selfrenewal. Cancer Res., 2008, 68(22), 9125-9130.
45. Jiang, L.; Song, L.; Wu, J.; Yang, Y.; Zhu, X.; Hu, B.; Cheng, S.Y.; Li, M. Bmi-1 promotes glioma angiogenesis by activating NFkappaB signaling. PLoS One, 2013, 8(1), e55527.